Wilkie, M. D., Anaam, E. A., Lau, A. S., Rubbi, C. P., Jones, T. M., Boyd, M. T., & Vlatković, N. (2020). TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapies. Cancer Letters, 478, 107-121. doi:10.1016/j.canlet.2020.02.032DOI: 10.1016/j.canlet.2020.02.032
